[1]
Ahmadi, A.; Mahmoudi, A. Synthesis with improved yield and study on the analgesic effect of 2-methoxyphencyclidine. Arzneimittelforschung, 2006, 56(5), 346-350. [PMID: 16821645].
[2]
al-Deeb, O.A.A. Synthesis and analgesic activity of new phencyclidine derivatives. Arzneimittelforschung, 1994, 44(10), 1141-1144. [PMID: 7818589].
[3]
Pechnick, R.N.; Bresee, C.J.; Poland, R.E. The role of antagonism of NMDA receptor-mediated neurotransmission and inhibition of the dopamine reuptake in the neuroendocrine effects of phencyclidine. Life Sci., 2006, 78(17), 2006-2011. [http://dx.doi.org/10.1016/j.lfs.2005.09.018]. [PMID: 16288927].
[4]
Albuquerque, E.X.; Aguayo, L.G.; Warnick, J.E.; Ickowicz, R.K.; Blaustein, M.P. Interactions of phencyclidine with ion channels of nerve and muscle: Behavioral implications. Fed. Proc., 1983, 42(9), 2584-2589. [PMID: 6303862].
[5]
Sircar, R.; Zukin, S. Further evidence of phencyclidine/sigma opioid receptor commonality. In: Phencyclidine: An Update, NIDA Research Monograph 64; Clouet, D.H., Ed.; National Institute on Drug Abuse: Rockville, MD, 1986; p. 14.
[6]
Diaz, J. How Drugs Influence Behavior: A Neurobehavioral Approach; Prentice Hall: Englewood Cliffs, 1996.
[7]
Ahmadi, A.; Khalili, M.; Hajikhani, R.; Naserbakht, M. New morpholine analogues of phencyclidine: chemical synthesis and pain perception in rats. Pharmacol. Biochem. Behav., 2011, 98(2), 227-233. [http://dx.doi.org/10.1016/j.pbb.2010.12.019]. [PMID: 21215770].
[8]
Ahmadi, A.; Kermani, M.; Naderi, N.; Hajikhani, R.; Rezaee, N.M.; Javadi, M.; Niknafs, B.N. Synthesis and antinociceptive behaviors of new methyl and hydroxyl derivatives of phencyclidine. Curr. Med. Chem., 2012, 19(5), 763-769. [http://dx.doi.org/10.2174/092986712798992057]. [PMID: 22214446].
[9]
Ahmadi, A.; Khalili, M.; Marami, S.; Ghadiri, A.; Nahri-Niknafs, B. Synthesis and pain perception of new analogues of phencyclidine in NMRI male mice. Mini Rev. Med. Chem., 2014, 14(1), 64-71. [http://dx.doi.org/10.2174/1389557513666131119203551]. [PMID: 24251803].
[10]
Ahmadi, A.; Khalili, M.; Fallah, M.; Nahri-Niknafs, B. Synthesis and analgesic properties of new modified analogs of phencyclidine with specific binding on PCP receptor or dopamine inhibition reuptake activities. Pharm. Chem. J., 2015, 49(9), 613-619. [http://dx.doi.org/10.1007/s11094-015-1339-0].
[11]
Ahmadi, A.; Khalili, M.; Barzin, M.; Pooladi, M.; Bakhtiari, F.; Barjeste, M.; Nahri-Niknafs, B. Synthesis and antinociception properties of phencyclidine derivatives with modified aromatic or cycloalkyl rings and amino group. Monatsh. Chem., 2016, 147(2), 457-464. [http://dx.doi.org/10.1007/s00706-015-1472-1].
[12]
Ahmadi, A.; Khalili, M.; Mirza, B.; Mohammadi-Diz, M.; Azami-Lorestani, F.; Ghaderi, P.; Nahri-Niknafs, B. Synthesis and antinociception activities of some novel derivatives of phencyclidine with substituted aminobenzothiazoles. Mini Rev. Med. Chem., 2017, 17(1), 78-84. [http://dx.doi.org/10.2174/1389557516666160428112532]. [PMID: 27121715].
[13]
Ahmadi, A.; Khalili, M.; Abbassi, S.; Javadi, M.; Mahmoudi, A.; Hajikhani, R. Synthesis and study on analgesic effects of 1-[1-[4-methylphenyl][cyclohexyl]-4-piperidinol and 1-[1-[4-methoxyphenyl][cyclohexyl]]-4-piperidinol as Two new phencyclidine derivatives. Arzneimittelforschung, 2009, 59(4), 202-206. [PMID: 19517897].
[14]
Okunrobo, L.O.; Usifoh, C.O. Ring opening of phthalimide derivatives with benzylamine: Formation of carboxamides and their pharmacological evaluation. Indian J. Pharm. Sci., 2007, 69(1), 96-100. [http://dx.doi.org/10.4103/0250-474X.32116].
[15]
Maeda, T.; Takase, M.; Ishibashi, A.; Yamamoto, T.; Sasaki, K.; Arika, T.; Yokoo, M.; Amemiya, K. Synthesis and antifungal activity of butenafine hydrochloride (KP-363), a new benzylamine antifungal agent. Yakugaku Zasshi, 1991, 111(2), 126-137. [http://dx.doi.org/10.1248/yakushi1947.111.2_126]. [PMID: 2056447].
[16]
Lommen, G.; De Bruyn, M.; Schroven, M.; Verschueren, W.; Janssens, W.; Verrelst, J.; Leysen, J. The discovery of a series of new non-indole 5HT1D agonists. Bioorg. Med. Chem. Lett., 1995, 5(22), 2649-2654. [http://dx.doi.org/10.1016/0960-894X(95)00473-7].
[17]
Choi, D.; Stables, J.P.; Kohn, H. Synthesis and anticonvulsant activities of N-Benzyl-2-acetamidopropionamide derivatives. J. Med. Chem., 1996, 39(9), 1907-1916. [http://dx.doi.org/10.1021/jm9508705]. [PMID: 8627614].
[18]
Morieux, P.; Stables, J.P.; Kohn, H. Synthesis and anticonvulsant activities of N-benzyl (2R)-2-acetamido-3-oxysubstituted propionamide derivatives. Bioorg. Med. Chem., 2008, 16(19), 8968-8975. [http://dx.doi.org/10.1016/j.bmc.2008.08.055]. [PMID: 18789868].
[19]
Peterson, U. Quinolone Antibiotics: The Development of Moxifloxacin. In: IUPAC, Analogue-based Drug Discovery; Fischer, J.; Ganellin, C.R., Eds.; John Wiley & Sons, 2006; pp. 338-342.
[20]
Van Lommen, G.R.E.; De Bruyn, M.F.L.; Schroven, M.F.J. Derivatives of 2,2'-iminobisethanol. US patent 4654362. 1987.
[21]
Dubuisson, D.; Dennis, S.G. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain, 1977, 4(2), 161-174. [http://dx.doi.org/10.1016/0304-3959(77)90130-0]. [PMID: 564014].
[22]
Ramabadran, K.; Bansinath, M.; Turndorf, H.; Puig, M.M. Tail immersion test for the evaluation of a nociceptive reaction in mice. Methodological considerations. J. Pharmacol. Methods, 1989, 21(1), 21-31. [http://dx.doi.org/10.1016/0160-5402(89)90019-3]. [PMID: 2704245].
[23]
Maddox, V.H.; Godefroi, E.F.; Parcell, R.F. The synthesis of phencyclidine and other larylcyclohexylamines. J. Med. Chem., 1965, 8, 230-235. [http://dx.doi.org/10.1021/jm00326a019]. [PMID: 14332667].
[24]
Ahmadi, A.; Solati, J.; Hajikhani, R.; Onagh, M.; Javadi, M. Synthesis and analgesic effects of 1-[1-(2-methylphenyl)(cyclohexyl)]-3-piperidinol as a new derivative of phencyclidine in mice. Arzneimittelforschung, 2010, 60(8), 492-496. [PMID: 20863005].
[25]
Bruylants, p. This study deals with the reaction of organo-magnesium compounds on nitriles. Bull. Soc. Chim. Belg., 1926, 35, 139-154.
[26]
Kalir, A.; Edery, H.; Pelah, Z.; Balderman, D.; Porath, G. 1-Phenycycloalkylamine derivatives. II. Synthesis and pharmacological activity. J. Med. Chem., 1969, 12(3), 473-477. [http://dx.doi.org/10.1021/jm00303a030]. [PMID: 4977945].
[27]
March, J. Advanced Organic Chemistry, Reactions. Mechanisms, and Structure, 2nd ed; McGraw-Hill: St. Louis, MO, 1977, p. 816.
[28]
Carey, F.A.; Sundberg, R.J. Advanced Organic Chemistry, Part B: Reactions and Synthesis; Plenum Press: New York, 1977, pp. 172-175.
[29]
Yoshimura, J.; Ohgo, Y.; Sato, T. Steric difference between the substitution reaction products of lithium alkyls and grignard reagents with α-aminonitriles. An asymmetric reproduction. J. Org. Chem., 1964, 86, 3858-3862.
[30]
Ferle-Vidović, A.; Kaštelan, M.; Petrović, D.; Šuman, L.; Kaselj, M.; Škare, D.; Mlinarić-Majerski, K. Synthesis and biological activity of phencyclidine and its adamantylamine derivatives. Eur. J. Med. Chem., 1993, 28(3), 243-250. [http://dx.doi.org/10.1016/0223-5234(93)90140-A].
[31]
Carlson, K.M.; Wagner, G.C. Effects of phencyclidine on schedule-controlled responding following neurotoxic lesions of the striatum. Life Sci., 2005, 77(4), 372-385. [http://dx.doi.org/10.1016/j.lfs.2004.08.043]. [PMID: 15894007].
[32]
Johnson, K.M.; Jones, S.M. Neuropharmacology of phencyclidine: Basic mechanisms and therapeutic potential. Annu. Rev. Pharmacol. Toxicol., 1990, 30, 707-750. [http://dx.doi.org/10.1146/annurev.pa.30.040190.003423]. [PMID: 2160793].